{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:27:33Z","timestamp":1791606453645,"version":"4.3.4"},"reference-count":185,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013028","name":"Frank McGraw Memorial Chair in Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP120214"],"award-info":[{"award-number":["RP120214"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP110595"],"award-info":[{"award-number":["RP110595"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA177909"],"award-info":[{"award-number":["CA177909"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA098258"],"award-info":[{"award-number":["P50 CA098258"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UH3TR000943"],"award-info":[{"award-number":["UH3TR000943"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA217685"],"award-info":[{"award-number":["P50 CA217685"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35 CA209904"],"award-info":[{"award-number":["R35 CA209904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001282","name":"Ovarian Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001282","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ccell.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T12:03:21Z","timestamp":1523534601000},"page":"965-983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":574,"title":["The Platelet Lifeline to Cancer: Challenges and Opportunities"],"prefix":"10.1016","volume":"33","author":[{"given":"Monika","family":"Haemmerle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Menter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Afshar-Kharghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2018.03.002_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-61779-307-3_12","article-title":"A rapid and efficient platelet purification protocol for platelet gene expression studies","volume":"788","author":"Amisten","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ccell.2018.03.002_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","article-title":"Pericytes: developmental, physiological, and pathological perspectives, problems, and promises","volume":"21","author":"Armulik","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ccell.2018.03.002_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib5","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood-2011-07-368050","article-title":"P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment","volume":"119","author":"Azab","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/fampra\/cmw100","article-title":"How useful is thrombocytosis in predicting an underlying cancer in primary care? A systematic review","volume":"34","author":"Bailey","year":"2017","journal-title":"Fam. Pract."},{"key":"10.1016\/j.ccell.2018.03.002_bib7","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.1073\/pnas.2234372100","article-title":"Platelet and osteoclast beta3 integrins are critical for bone metastasis","volume":"100","author":"Bakewell","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.03.002_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","article-title":"The platelet contribution to cancer progression","volume":"9","author":"Bambace","year":"2011","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/09537100903470298","article-title":"The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets","volume":"21","author":"Bambace","year":"2010","journal-title":"Platelets"},{"key":"10.1016\/j.ccell.2018.03.002_bib10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1182\/blood-2011-02-334524","article-title":"Release of angiogenesis regulatory proteins from platelet\u00a0alpha granules: modulation of physiologic and pathologic angiogenesis","volume":"118","author":"Battinelli","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood-2013-02-485011","article-title":"Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response","volume":"123","author":"Battinelli","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/00042728-200506000-00011","article-title":"Normal cutaneous wound healing: clinical correlation with cellular and molecular events","volume":"31","author":"Baum","year":"2005","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.ccell.2018.03.002_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10585-016-9826-6","article-title":"Melanoma cell metastasis via P-selectin-mediated activation of acid sphingomyelinase in platelets","volume":"34","author":"Becker","year":"2017","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.ccell.2018.03.002_bib14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1160\/TH06-02-0069","article-title":"Platelet-induced growth of human fibroblasts is associated with an increased expression of 5-lipoxygenase","volume":"96","author":"Berg","year":"2006","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","article-title":"RNA-seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics","volume":"28","author":"Best","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2018.03.002_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ccell.2018.03.002_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study","volume":"4","author":"Blom","year":"2006","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib18","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.061615598","article-title":"Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis","volume":"98","author":"Borsig","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.03.002_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1078-0432.CCR-14-0870","article-title":"Differential platelet levels affect response to taxane-based therapy in ovarian cancer","volume":"21","author":"Bottsford-Miller","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib20","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI200422123","article-title":"Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer","volume":"114","author":"Boucharaba","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2018.03.002_bib21","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","article-title":"Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial","volume":"378","author":"Burn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2018.03.002_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.blre.2014.04.002","article-title":"Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine","volume":"28","author":"Burnouf","year":"2014","journal-title":"Blood Rev."},{"key":"10.1016\/j.ccell.2018.03.002_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2004-02-0434","article-title":"Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis","volume":"104","author":"Camerer","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2018.03.002_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2018.03.002_bib26","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1016\/j.febslet.2006.08.082","article-title":"Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton","volume":"580","author":"Cauwenberghs","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ccell.2018.03.002_bib27","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2010-12-324517","article-title":"Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events","volume":"118","author":"Cecchetti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2009.1112","article-title":"Aspirin use and survival after diagnosis of colorectal cancer","volume":"302","author":"Chan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ccell.2018.03.002_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/532269a","article-title":"The tumour trail left in blood","volume":"532","author":"Chi","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2018.03.002_bib30","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1182\/blood-2012-06-438598","article-title":"Platelets increase the proliferation of ovarian cancer cells","volume":"120","author":"Cho","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib31","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood-2017-02-769893","article-title":"Role of ADP receptors on platelets in the growth of ovarian cancer","volume":"130","author":"Cho","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/gut.2010.221143","article-title":"Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer","volume":"60","author":"Coghill","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.ccell.2018.03.002_bib33","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2018.03.002_bib34","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/cam4.86","article-title":"Increased platelet reactivity in patients with late-stage metastatic cancer","volume":"2","author":"Cooke","year":"2013","journal-title":"Cancer Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib35","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1042\/BST20150282","article-title":"Proteinase-activated receptors (PARs) as targets for antiplatelet therapy","volume":"44","author":"Cunningham","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ccell.2018.03.002_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11239-011-0667-5","article-title":"P2Y12 platelet inhibition in clinical practice","volume":"33","author":"Damman","year":"2012","journal-title":"J.\u00a0Thromb. Thrombolysis"},{"key":"10.1016\/j.ccell.2018.03.002_bib37","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00109-013-1074-5","article-title":"Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond","volume":"91","author":"Danckwardt","year":"2013","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0952-3278(02)00235-1","article-title":"Pharmacological evaluation of the novel thromboxane modulator BM-567 (II\/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation","volume":"68","author":"de Leval","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.ccell.2018.03.002_bib39","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1158\/0008-5472.CAN-10-2038","article-title":"Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice","volume":"71","author":"Demers","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib40","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/ijc.28165","article-title":"Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K\/Akt\/NF-kappaB","volume":"133","author":"Dilly","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ccell.2018.03.002_bib41","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2015-04-640300","article-title":"Platelet microparticles inhibit IL-17 production by regulatory T\u00a0cells through P-selectin","volume":"127","author":"Dinkla","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib42","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1158\/1078-0432.CCR-09-3122","article-title":"Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer","volume":"16","author":"Dorff","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/mol.113.084988","article-title":"Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells","volume":"84","author":"Dovizio","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ccell.2018.03.002_bib44","doi-asserted-by":"crossref","first-page":"e26125","DOI":"10.1371\/journal.pone.0026125","article-title":"Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells","volume":"6","author":"Egan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2018.03.002_bib45","doi-asserted-by":"crossref","first-page":"e000467","DOI":"10.1161\/JAHA.113.000467","article-title":"D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model","volume":"3","author":"Eichinger","year":"2014","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.ccell.2018.03.002_bib46","doi-asserted-by":"crossref","first-page":"e0152402","DOI":"10.1371\/journal.pone.0152402","article-title":"Aspirin in the treatment of cancer: reductions in metastatic spread and in mortality: a systematic review and meta-analyses of published studies","volume":"11","author":"Elwood","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2018.03.002_bib47","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3109\/09537104.2015.1051953","article-title":"Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets","volume":"26","author":"Etulain","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.ccell.2018.03.002_bib48","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/13522","article-title":"Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice","volume":"5","author":"Fabre","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib49","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/09537104.2016.1174204","article-title":"Platelets are not hyperreactive in patients with ovarian cancer","volume":"27","author":"Feng","year":"2016","journal-title":"Platelets"},{"key":"10.1016\/j.ccell.2018.03.002_bib50","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1586\/erc.10.154","article-title":"Targeting von Willebrand factor and platelet glycoprotein Ib receptor","volume":"8","author":"Firbas","year":"2010","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.ccell.2018.03.002_bib51","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2008-06-163832","article-title":"Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles","volume":"113","author":"Flaumenhaft","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib52","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/archinternmed.2010.154","article-title":"Prasugrel as a potential cancer promoter: review of the unpublished data","volume":"170","author":"Floyd","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1083\/jcb.111.2.483","article-title":"Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane","volume":"111","author":"Fox","year":"1990","journal-title":"J.\u00a0Cell Biol"},{"issue":"Suppl 1","key":"10.1016\/j.ccell.2018.03.002_bib54","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.thromres.2010.01.036","article-title":"Formation of procoagulant microparticles and properties","volume":"125","author":"Freyssinet","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib55","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1182\/blood-2010-09-307751","article-title":"Heparin promotes platelet responsiveness by potentiating alphaIIbbeta3-mediated outside-in signaling","volume":"117","author":"Gao","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1073\/pnas.61.1.46","article-title":"Antimetastatic effects associated with platelet reduction","volume":"61","author":"Gasic","year":"1968","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.03.002_bib57","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1182\/blood-2013-05-468694","article-title":"Platelets in tissue repair: control of apoptosis and interactions with regenerative cells","volume":"122","author":"Gawaz","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib58","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI112582","article-title":"Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery","volume":"78","author":"George","year":"1986","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2018.03.002_bib59","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1182\/blood.V60.4.834.834","article-title":"Isolation of human platelet membrane microparticles from plasma and serum","volume":"60","author":"George","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.transci.2014.12.015","article-title":"Platelet microparticle: a sensitive physiological \"fine tuning\" balancing factor in health and disease","volume":"52","author":"Goubran","year":"2015","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.ccell.2018.03.002_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1359-6101(99)00037-4","article-title":"TGF-beta in blood: a complex problem","volume":"11","author":"Grainger","year":"2000","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ccell.2018.03.002_bib62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/ATVBAHA.115.306777","article-title":"Cell-penetrating pepducin therapy targeting PAR1 in subjects with coronary artery disease","volume":"36","author":"Gurbel","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ccell.2018.03.002_bib63","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1172\/JCI85086","article-title":"FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal","volume":"126","author":"Haemmerle","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2018.03.002_bib64","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41467-017-00411-z","article-title":"Platelets reduce anoikis and promote metastasis by activating YAP1 signaling","volume":"8","author":"Haemmerle","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2018.03.002_bib65","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1182\/blood.V94.11.3791","article-title":"Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules","volume":"94","author":"Heijnen","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib66","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.eururo.2008.06.038","article-title":"Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy","volume":"56","author":"Helley","year":"2009","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ccell.2018.03.002_bib68","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","article-title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study","volume":"27","author":"Heng","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature12501","article-title":"Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2","volume":"502","author":"Herzog","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2018.03.002_bib70","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1055\/s-0037-1615937","article-title":"Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread","volume":"82","author":"Hettiarachchi","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib71","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2353\/ajpath.2009.090460","article-title":"Innate immune cells induce hemorrhage in tumors during thrombocytopenia","volume":"175","author":"Ho-Tin-No\u00e9","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2018.03.002_bib72","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1158\/0008-5472.CAN-08-0718","article-title":"Platelet granule secretion continuously prevents intratumor hemorrhage","volume":"68","author":"Ho-Tin-No\u00e9","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib73","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1158\/0008-5472.CAN-09-1370","article-title":"Platelets: guardians of tumor vasculature","volume":"69","author":"Ho-Tin-No\u00e9","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib74","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/cts.12070","article-title":"Initiation of aspirin therapy modulates angiogenic protein levels in women with breast cancer receiving tamoxifen therapy","volume":"6","author":"Holmes","year":"2013","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ccell.2018.03.002_bib75","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1160\/TH06-03-0141","article-title":"Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer","volume":"97","author":"Hron","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib76","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1158\/1078-0432.CCR-16-3272","article-title":"Role of platelet-derived Tgf\u03b21 in the progression of ovarian cancer","volume":"23","author":"Hu","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib77","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbacli.2016.06.003","article-title":"Lipid profile of platelets and platelet-derived microparticles in ovarian cancer","volume":"6","author":"Hu","year":"2016","journal-title":"BBA Clin."},{"key":"10.1016\/j.ccell.2018.03.002_bib78","first-page":"328","article-title":"Ovarian cancer: FAK\u2014new target for antiangiogenic therapy","volume":"13","author":"Hutchinson","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib79","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF02573067","article-title":"Poor prognosis associated with thrombocytosis in patients with gastric cancer","volume":"9","author":"Ikeda","year":"2002","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib80","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood-2007-09-113837","article-title":"Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet\u00a0alpha granules and differentially released","volume":"111","author":"Italiano","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib81","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1538-7836.2009.03559.x","article-title":"Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models","volume":"7","author":"Jain","year":"2009","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib82","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1073\/pnas.0700625104","article-title":"Platelet glycoprotein Ib alpha supports experimental lung metastasis","volume":"104","author":"Jain","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.03.002_bib83","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1182\/blood.V98.10.3143","article-title":"Platelet-derived microparticles bind to hematopoietic stem\/progenitor cells and enhance their engraftment","volume":"98","author":"Janowska-Wieczorek","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib84","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm1400","article-title":"Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes","volume":"12","author":"Jin","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib85","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thromres.2003.10.012","article-title":"Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study","volume":"112","author":"Jurasz","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib86","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/j.1538-7836.2006.02192.x","article-title":"Nucleotide receptor signaling in platelets","volume":"4","author":"Kahner","year":"2006","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib87","first-page":"885","article-title":"Perioperative heparin-therapy inhibits late death from metastatic cancer","volume":"6","author":"Kakkar","year":"1995","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib88","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1200\/JCO.2004.10.002","article-title":"Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS)","volume":"22","author":"Kakkar","year":"2004","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib89","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib90","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1038\/onc.2012.447","article-title":"Platelets govern pre-metastatic tumor communication to bone","volume":"32","author":"Kerr","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2018.03.002_bib91","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1200\/JCO.2009.22.3271","article-title":"Assessing risk of venous thromboembolism in the patient with cancer","volume":"27","author":"Khorana","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib92","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib93","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/cncr.21496","article-title":"Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study","volume":"104","author":"Khorana","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ccell.2018.03.002_bib94","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1245\/s10434-014-3988-8","article-title":"Clinical significance of thrombocytosis before preoperative chemoradiotherapy in rectal cancer: predicting pathologic tumor response and oncologic outcome","volume":"22","author":"Kim","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib95","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2141.2003.04773.x","article-title":"Platelet microparticles induce angiogenesis in\u00a0vitro","volume":"124","author":"Kim","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ccell.2018.03.002_bib96","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0959-8049(02)00596-8","article-title":"Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor","volume":"39","author":"Kim","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ccell.2018.03.002_bib97","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1073\/pnas.95.16.9325","article-title":"P-selectin deficiency attenuates tumor growth and metastasis","volume":"95","author":"Kim","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.03.002_bib98","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood-2008-06-159541","article-title":"Platelets actively sequester angiogenesis regulators","volume":"113","author":"Klement","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib99","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1200\/JCO.2005.03.134","article-title":"The effect of low molecular weight heparin on survival in patients with advanced malignancy","volume":"23","author":"Klerk","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib100","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1158\/0008-5472.CAN-09-2123","article-title":"Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity","volume":"69","author":"Kopp","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib101","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/sj.bjc.6603923","article-title":"Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer","volume":"97","author":"Kut","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2018.03.002_bib102","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2018.03.002_bib103","doi-asserted-by":"crossref","first-page":"E3053","DOI":"10.1073\/pnas.1411082111","article-title":"Platelets guide the formation of early metastatic niches","volume":"111","author":"Labelle","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.03.002_bib104","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.semcancer.2010.04.005","article-title":"Selectins promote tumor metastasis","volume":"20","author":"L\u00e4ubli","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ccell.2018.03.002_bib105","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.amjmed.2017.01.022","article-title":"The effect of combined aspirin and clopidogrel treatment on cancer incidence","volume":"130","author":"Leader","year":"2017","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib106","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1182\/blood-2014-04-568683","article-title":"Interaction of platelet-derived autotaxin with tumor integrin alphaVbeta3 controls metastasis of breast cancer cells to bone","volume":"124","author":"Leblanc","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib107","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib108","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1200\/JCO.2005.03.133","article-title":"Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism","volume":"23","author":"Lee","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib109","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd724","article-title":"Novel drug development opportunities for heparin","volume":"1","author":"Lever","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2018.03.002_bib110","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archinte.1964.03860100079008","article-title":"Thrombocytosis associated with malignant disease","volume":"114","author":"Levin","year":"1964","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib111","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biomaterials.2015.10.046","article-title":"Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles","volume":"76","author":"Li","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ccell.2018.03.002_bib112","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2407-14-167","article-title":"Presence of intratumoral platelets is associated with tumor vessel structure and metastasis","volume":"14","author":"Li","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ccell.2018.03.002_bib113","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-015-0327-z","article-title":"MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3","volume":"14","author":"Liang","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ccell.2018.03.002_bib114","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","article-title":"Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival","volume":"367","author":"Liao","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib115","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1073\/pnas.111150798","article-title":"Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release","volume":"98","author":"Ma","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.03.002_bib116","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1200\/JCO.2015.64.0268","article-title":"Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial","volume":"34","author":"Macbeth","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib117","doi-asserted-by":"crossref","first-page":"e88245","DOI":"10.1172\/jci.insight.88245","article-title":"Platelet integrin alpha6beta1 controls lung metastasis through direct binding to cancer cell-derived ADAM9","volume":"1","author":"Mammadova-Bach","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ccell.2018.03.002_bib118","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30\u00a0months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib119","first-page":"109","article-title":"Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study","volume":"7","author":"Menter","year":"1987","journal-title":"Invasion Metastasis"},{"key":"10.1016\/j.ccell.2018.03.002_bib120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00116627","article-title":"Tumor cell-platelet interactions in\u00a0vitro and their relationship to in\u00a0vivo arrest of hematogenously circulating tumor cells","volume":"5","author":"Menter","year":"1987","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.ccell.2018.03.002_bib121","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/ATVBAHA.114.303413","article-title":"Current state and novel approaches of antiplatelet therapy","volume":"35","author":"Metharom","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ccell.2018.03.002_bib122","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/blood-2011-09-377648","article-title":"Platelet TGF-beta1 contributions to plasma TGF-beta1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload","volume":"119","author":"Meyer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib123","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood-2016-11-751099","article-title":"Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth","volume":"130","author":"Michael","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib124","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1073\/pnas.94.2.663","article-title":"Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets","volume":"94","author":"Mohle","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.03.002_bib125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/jpet.112.200881","article-title":"Pharmacologic protein kinase C\u03b1 inhibition uncouples human platelet-stimulated angiogenesis from collagen-induced aggregation","volume":"345","author":"Moncada de la Rosa","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ccell.2018.03.002_bib126","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm.3541","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","volume":"20","author":"Motz","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib127","first-page":"143","article-title":"Crosstalk between platelets and PBMC: new evidence in wound healing","volume":"27","author":"Nami","year":"2016","journal-title":"Platelets"},{"key":"10.1016\/j.ccell.2018.03.002_bib128","first-page":"1295","article-title":"Lysis of tumor cells by natural killer cells in mice is impeded by platelets","volume":"59","author":"Nieswandt","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib129","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1182\/blood-2011-03-344408","article-title":"Blood platelets contain tumor-derived RNA biomarkers","volume":"118","author":"Nilsson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib130","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.18632\/oncotarget.6279","article-title":"Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer","volume":"7","author":"Nilsson","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2018.03.002_bib131","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0021-9150(01)00433-6","article-title":"High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells","volume":"158","author":"Nomura","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ccell.2018.03.002_bib132","first-page":"102","article-title":"Thromboxane production by platelets during tumor cell-induced platelet activation","volume":"11","author":"Pacchiarini","year":"1991","journal-title":"Invasion Metastasis"},{"key":"10.1016\/j.ccell.2018.03.002_bib133","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1538-7836.2008.02938.x","article-title":"Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function","volume":"6","author":"Palumbo","year":"2008","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib134","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2004-06-2272","article-title":"Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells","volume":"105","author":"Palumbo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib135","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1183\/09031936.96.09091826","article-title":"Prognostic significance of thrombocytosis in patients with primary lung cancer","volume":"9","author":"Pedersen","year":"1996","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ccell.2018.03.002_bib136","first-page":"1713","article-title":"Protection from tumor necrosis factor-mediated cytolysis by platelets","volume":"143","author":"Philippe","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2018.03.002_bib137","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-11-1872","article-title":"Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells","volume":"72","author":"Placke","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib138","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0140-6736(92)91054-C","article-title":"Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis","volume":"339","author":"Prandoni","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2018.03.002_bib139","doi-asserted-by":"crossref","first-page":"679","DOI":"10.7150\/ijbs.11589","article-title":"P-selectin-mediated adhesion between platelets and tumor cells promotes intestinal tumorigenesis in Apc(Min\/+) mice","volume":"11","author":"Qi","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ccell.2018.03.002_bib140","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.18632\/oncotarget.3164","article-title":"P-selectin-mediated platelet adhesion promotes tumor growth","volume":"6","author":"Qi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2018.03.002_bib141","doi-asserted-by":"crossref","first-page":"e91320","DOI":"10.1371\/journal.pone.0091320","article-title":"P-selectin-mediated platelet adhesion promotes the metastasis of murine melanoma cells","volume":"9","author":"Qi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2018.03.002_bib142","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai7911","article-title":"Platelets subvert T\u00a0cell immunity against cancer via GARP-TGF\u03b2 axis","volume":"2","author":"Rachidi","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ccell.2018.03.002_bib143","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1476-5381.2012.01991.x","article-title":"Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance","volume":"167","author":"Radziwon-Balicka","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ccell.2018.03.002_bib144","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamainternmed.2014.511","article-title":"Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer","volume":"174","author":"Reimers","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1160\/TH16-02-0123","article-title":"Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis","volume":"117","author":"Riedl","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib146","first-page":"237","article-title":"Zur pathologischen Anatomie des Blutes","author":"Riess","year":"1872","journal-title":"Arch. Anat. Physiol. Wiss. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib147","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1373\/clinchem.2005.049486","article-title":"Optimized procedure for platelet RNA profiling from blood samples with limited platelet numbers","volume":"51","author":"Rolf","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ccell.2018.03.002_bib148","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/sj.bjc.6605872","article-title":"A phase I\/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer","volume":"103","author":"Rossi","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2018.03.002_bib149","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2018.03.002_bib150","doi-asserted-by":"crossref","first-page":"27960","DOI":"10.1074\/jbc.M704039200","article-title":"Beta2-integrins and acquired glycoprotein IIb\/IIIa (GPIIb\/IIIa) receptors cooperate in NF-kappaB activation of human neutrophils","volume":"282","author":"Salanova","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2018.03.002_bib151","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1016611230747","article-title":"Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study","volume":"4","author":"Salgado","year":"2001","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ccell.2018.03.002_bib152","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0037-1613051","article-title":"Venous thrombosis in patients with solid tumors: determination of frequency and characteristics","volume":"87","author":"Sallah","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib153","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00268-011-1329-7","article-title":"Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer","volume":"36","author":"Sasaki","year":"2012","journal-title":"World J. Surg."},{"key":"10.1016\/j.ccell.2018.03.002_bib154","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood-2013-12-544445","article-title":"Platelets induce apoptosis via membrane-bound FasL","volume":"126","author":"Schleicher","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib155","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ccr.2013.05.008","article-title":"Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor","volume":"24","author":"Schumacher","year":"2013","journal-title":"Cancer cell"},{"key":"10.1016\/j.ccell.2018.03.002_bib156","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-61779-307-3_11","article-title":"Assessing protein synthesis by platelets","volume":"788","author":"Schwertz","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ccell.2018.03.002_bib157","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000431356","article-title":"The dual antiplatelet therapy trial after the FDA update: noncardiovascular deaths, cancer and optimal treatment duration","volume":"132","author":"Serebruany","year":"2015","journal-title":"Cardiology"},{"key":"10.1016\/j.ccell.2018.03.002_bib158","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-2007-991540","article-title":"Inhibition of platelet function: does it offer a chance of better cancer progression control?","volume":"33","author":"Sierko","year":"2007","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib159","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.amjmed.2005.06.058","article-title":"Incidence of venous thromboembolism in patients hospitalized with cancer","volume":"119","author":"Stein","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib160","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib161","doi-asserted-by":"crossref","first-page":"25993","DOI":"10.1074\/jbc.M702327200","article-title":"Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells","volume":"282","author":"Suzuki-Inoue","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2018.03.002_bib162","doi-asserted-by":"crossref","first-page":"e73609","DOI":"10.1371\/journal.pone.0073609","article-title":"Platelets promote tumor growth and metastasis via direct interaction between Aggrus\/podoplanin and CLEC-2","volume":"8","author":"Takagi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2018.03.002_bib163","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1055\/s-0037-1613413","article-title":"Impact of pretreatment thrombocytosis on survival in primary breast cancer","volume":"89","author":"Taucher","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib164","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1538-7836.2009.03504.x","article-title":"Microparticle-associated tissue factor activity in cancer patients with and without thrombosis","volume":"7","author":"Tesselaar","year":"2009","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib165","first-page":"2824","article-title":"Multiple roles for platelet GPIIb\/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis","volume":"62","author":"Trikha","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib166","series-title":"Lectures on Clinical Medicine, Delivered at the Hotel-Dieu","first-page":"281","author":"Trousseau","year":"1865"},{"key":"10.1016\/j.ccell.2018.03.002_bib167","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood-2009-04-216069","article-title":"Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation","volume":"115","author":"Uhrin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib168","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.110.980623","article-title":"Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans","volume":"123","author":"Ungerer","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ccell.2018.03.002_bib169","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1160\/TH12-02-0099","article-title":"Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study","volume":"108","author":"van Doormaal","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ccell.2018.03.002_bib170","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cvr\/cvu113","article-title":"Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets","volume":"103","author":"van Holten","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib171","series-title":"Essentials of Glycobiology","article-title":"Glycosylation changes in cancer","author":"Varki","year":"2009"},{"key":"10.1016\/j.ccell.2018.03.002_bib172","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1158\/1078-0432.CCR-07-0847","article-title":"Platelets take up the monoclonal antibody bevacizumab","volume":"13","author":"Verheul","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib173","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1158\/0008-5472.CAN-08-0419","article-title":"Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice","volume":"68","author":"Versteeg","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.03.002_bib174","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood.V82.9.2704.2704","article-title":"Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C","volume":"82","author":"Vezza","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib175","doi-asserted-by":"crossref","first-page":"14266","DOI":"10.1073\/pnas.1518628112","article-title":"Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancer","volume":"112","author":"Wang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.03.002_bib176","doi-asserted-by":"crossref","first-page":"e80780","DOI":"10.1371\/journal.pone.0080780","article-title":"Platelet P2Y12 is involved in murine pulmonary metastasis","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2018.03.002_bib177","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1182\/blood-2012-08-450072","article-title":"Fragmenting the platelet to reduce metastasis","volume":"120","author":"Ware","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib178","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.4049\/jimmunol.134.6.4267","article-title":"Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver","volume":"134","author":"Wiltrout","year":"1985","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2018.03.002_bib179","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2018.03.002_bib180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.1967.tb08741.x","article-title":"The nature and significance of platelet products in human plasma","volume":"13","author":"Wolf","year":"1967","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ccell.2018.03.002_bib181","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1053\/j.seminoncol.2014.04.007","article-title":"Pharmacological regulation of platelet factors that influence tumor angiogenesis","volume":"41","author":"Yan","year":"2014","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib182","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00432-016-2131-6","article-title":"Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms","volume":"142","author":"Zhang","year":"2016","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ccell.2018.03.002_bib183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10585-010-9353-9","article-title":"Platelet adhesion and fusion to endothelial cell facilitate the metastasis of tumor cell in hypoxia-reoxygenation condition","volume":"28","author":"Zhang","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.ccell.2018.03.002_bib184","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1182\/blood-2012-04-425207","article-title":"A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment","volume":"120","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.03.002_bib185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fendo.2014.00067","article-title":"Biased signaling of protease-activated receptors","volume":"5","author":"Zhao","year":"2014","journal-title":"Front. Endocrinol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610818300709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610818300709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:56Z","timestamp":1761523256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610818300709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":185,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1535610818300709"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2018.03.002","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Platelet Lifeline to Cancer: Challenges and Opportunities","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}